GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. NVAX today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday, November 7, 2017.
Conference call details are as follows:
Date: | Tuesday, November 7, 2017 |
Time: | 4:30 p.m. U.S. Eastern Time (ET) |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: | 2479419 |
Webcast: | www.novavax.com, "Investors"/ "Events" |
Conference call and webcast replay:
Dates: | Starts at 7:30 p.m. ET, Nov. 7, 2017 until 7:30 p.m. ET, Nov. 14, 2017 |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: | 2479419 |
Webcast: | www.novavax.com, "Investors"/ "Events", until February 7, 2018 |
About Novavax
Novavax, Inc. NVAX is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
Contact:
Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
ir@novavax.com
240-268-2000
Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506
Media
Russo Partners, LLC
David Schull
Maggie Beller
david.schull@russopartnersllc.com
maggie.beller@russopartnersllc.com
212-845-4271
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.